Home / Drugs / Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

FDA Drug Profile — Arexvy

Drug Details

Generic Name
Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted
Brand Names
Arexvy
Application Number
BLA125775
Sponsor
GlaxoSmithKline Biologicals SA
NDC Codes
1
Dosage Forms
KIT
Routes
N/A
Active Ingredients
N/A